File · dupont-pfoa

Parkersburg, West Virginia along the Ohio River. The DuPont Washington Works chemical plant — the principal North American producer of perfluorooctanoic acid (PFOA, 'C8') from 1951 until 2015 — operates on the river's edge approximately 4 km upstream of this view. Wikimedia Commons, CC BY-SA 2.5.

DuPont and PFOA

Parkersburg, West Virginia — the chemistry behind Teflon

Category: Corporate Cover-ups
Published: May 26, 2026
Length: 3,700 words · 17 min read
Author: The editors

DuPont and PFOA

Parkersburg, West Virginia — the chemistry behind Teflon.

Summary

PFOA — perfluorooctanoic acid, internally referred to at DuPont and 3M as "C8" — was used from the late 1940s onward as a processing aid in the manufacture of polytetrafluoroethylene (PTFE / Teflon) and other fluoropolymer products. It was produced primarily by 3M in Minnesota and DuPont in West Virginia and sold across the U.S. industrial supply chain. DuPont opened its Washington Works plant on the Ohio River near Parkersburg, West Virginia in 1948 and began full PFOA-using PTFE production in 1951. From the 1960s onward, DuPont's internal toxicology studies — held confidential — had documented serious adverse effects in laboratory animals exposed to PFOA. Internal animal studies in 1981 showed birth defects (cleft palate, microphthalmia) in offspring of female rats exposed to PFOA during pregnancy. The company did not communicate these findings to the U.S. Environmental Protection Agency (EPA), as it was required to do under the Toxic Substances Control Act of 1976. The agency only learned of the findings 23 years later, during the 2001 discovery process of Robert Bilott's class-action lawsuit. In 2005, the EPA fined DuPont $16.5 million for the disclosure failure — the largest U.S. environmental enforcement fine to that date. Bilott's parallel personal-injury class action against DuPont was settled in 2005 with a commitment to fund a C8 Science Panel — an independent epidemiological study of approximately 69,000 exposed residents of the lower Ohio River Valley. The panel's 2012 findings causally linked PFOA exposure to six health conditions: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension, and high cholesterol. The 2017 multi-district litigation settled approximately 3,550 individual personal-injury cases for $670.7 million. DuPont's production of PFOA ended in 2015 under EPA's PFOA Stewardship Program. Approximately 99% of Americans have detectable PFOA in their blood, with median levels of 3-5 ng/mL as of the 2017-2018 CDC NHANES survey.

What we know:

DuPont produced PFOA at its Washington Works plant in Parkersburg, West Virginia from 1951 to 2015.
DuPont's internal studies through the 1960s and 1970s documented PFOA's toxicity and bioaccumulation in laboratory animals and in workers' blood.
1981 internal DuPont studies documented birth defects in offspring of exposed female rats.
DuPont removed pregnant women from PFOA-handling production lines in 1981 but did not disclose the underlying studies to the EPA, as required under TSCA.
Wilbur Tennant's farm on Dry Run Creek, 3 miles downstream of the plant, lost approximately 153 cattle between 1996 and 2000.
Robert Bilott's 2001 class-action lawsuit (Leach v. DuPont) was settled in 2005 with the establishment of the independent C8 Science Panel.
The C8 Science Panel's 2012 findings established "probable link" between PFOA exposure and six diseases.
The 2017 MDL personal-injury settlement was $670.7 million across approximately 3,550 plaintiffs.
3M voluntarily phased out PFOA in 2002; DuPont followed via the EPA PFOA Stewardship Program by 2015.

What we don't know with certainty:

The total volume of PFOA released into the Ohio River and into Parkersburg-area landfills between 1951 and 2015. DuPont's own internal records show partial accounting; the full accounting has never been independently audited.
The complete list of communities downstream of the Washington Works plant with PFOA in drinking water at levels above the 2020 EPA health advisory of 70 ng/L (later revised in 2022 to 0.004 ng/L for PFOA).
The full health impact on the C8 Health Project cohort beyond the six "probable link" diseases established in 2012.
Whether the "successor" chemicals (GenX/HFPO-DA, introduced by DuPont and Chemours from 2009) carry similar risks. Animal studies have shown overlapping toxicology; long-term human studies are incomplete.

What Wilbur Tennant called about

An empty cattle pasture in Appalachian West Virginia at first light — rolling green-and-brown hills, weathered wooden fencing, a rusty cattle gate, a small clear creek running through the pasture; muddied ground at the creek's edges; a few patches of yellowed grass. — An imagined Appalachian cattle pasture of the period. Wilbur Tennant's 200-acre farm on Dry Run Creek, three miles downstream from the DuPont Washington Works plant, lost approximately 153 cattle between 1996 and 2000. Tennant filmed the deaths on a home video camera and brought the tape to Cincinnati lawyer Robert Bilott in 1999. Generated illustration; AI disclosure on About.

Wilbur Tennant was a 59-year-old cattle farmer in Lubeck, West Virginia. His family had farmed the same Appalachian valley land since the 1850s. His 200-acre property bordered Dry Run Creek, a small tributary that flowed past his property and into the Ohio River. The DuPont Washington Works plant — known locally as just "the plant" — sat three miles upstream.

Beginning in the mid-1990s, Tennant's cattle began dying in unusual ways. The deaths were not from any of the standard agricultural causes — not parasites, not nutritional deficiency, not infectious disease. They were neurological: cattle would develop staggering gaits, foam at the mouth, and die over days rather than hours. Some had visible tumors. Some had teeth that fell out. Tennant lost 153 head of cattle between 1996 and 2000 — more than half his herd.

Tennant was, by temperament, a careful witness. He bought a consumer-grade VHS camcorder. He filmed the cattle as they died. He filmed the creek. He filmed what he saw at the plant boundary — foam on the water, dead deer, what he described as "soapy" discharge. He kept the tapes.

The state environmental authorities, when Tennant complained, characterized the deaths as routine agricultural mortality and declined to investigate. The federal EPA, similarly. The local veterinarians, similarly.

In October 1998, Tennant called the only lawyer he could think of. His wife's friend's grandmother — Alma White Bilott — lived in nearby Vienna, West Virginia. Her grandson Robert was a corporate-defense lawyer at a prestigious Cincinnati firm named Taft Stettinius & Hollister. Tennant called Robert Bilott in his Cincinnati office.

The lawyer

Why isn't there a photograph of Robert Bilott here? No Creative-Commons or public-domain photographs of Robert Bilott exist on Wikimedia Commons. The press photographs of him are owned by Getty, AP, and similar agencies and are licensed for news use. We don't reproduce them here. He is a corporate- defense lawyer turned environmental advocate — partner at Taft Stettinius & Hollister in Cincinnati — who took on a single West Virginia cattle case in 1999 and spent the next twenty years exposing the largest American environmental cover-up of the late 20th century. His 2019 memoir, Exposure: Poisoned Water, Corporate Greed, and One Lawyer's Twenty-Year Battle Against DuPont, is the primary first-person source. He plays himself, in the 2019 Todd Haynes film Dark Waters, as portrayed by Mark Ruffalo. The film's title comes from a phrase Bilott used to describe the dump-site landfill records.

Bilott was 33 years old when Tennant called. He had been at Taft for seven years. His practice was for chemical companies, not against them. He had defended Chevron in environmental cases. He had defended DuPont in unrelated cases. He had defended Conoco. He understood the chemistry, the regulatory framework, the internal documents that mattered.

He took the Tennant case because his grandmother had asked him to look at it. He drove to Vienna, West Virginia in November 1998 and watched Wilbur Tennant's tapes.

The tapes were unambiguous. Whatever was killing the cattle was not routine. Bilott called the EPA's Office of Pollution Prevention and Toxics. He asked what they could tell him about DuPont's chemical releases at the Parkersburg plant. The EPA's records showed routine reporting on dozens of common chemicals — but, Bilott noticed, no listing for any chemical with the specific properties Tennant's cattle deaths suggested.

He filed a discovery motion. He asked for all internal documents DuPont had on chemical releases at the Washington Works plant.

The federal judge — Joseph R. Goodwin of the U.S. District Court for the Southern District of West Virginia — granted the motion in 2000. Over the next year, DuPont produced approximately 110,000 pages of internal documents.

It is in these documents that the story actually begins.

What was in the documents

A large industrial chemical plant complex viewed from across a wide river at twilight — white-painted distillation towers, tall chimney releasing white steam, low warehouse buildings, a long pier extending into the river; the river reflects the plant lights; bare trees and tall reeds on the near shore. — An imagined Ohio Valley chemical plant complex of the period. The DuPont Washington Works plant along the Ohio River near Parkersburg, West Virginia operated from 1948 and reached peak chemical production in the 1960s-1980s. Generated illustration; AI disclosure on About.

PFOA is a synthetic fluorochemical. Its chemical formula is C₈HF₁₅O₂ — an eight-carbon chain (hence the industry name "C8") in which seven of the eight carbons are fully fluorinated and the eighth carries a carboxylic acid group. The carbon-fluorine bond is one of the strongest single covalent bonds in chemistry. PFOA does not naturally degrade. It is what later regulatory literature would call a forever chemical.

PFOA's industrial usefulness comes from this same chemical stability. As a processing aid in the manufacture of PTFE (polytetrafluoroethylene — the polymer DuPont sold as Teflon), PFOA serves as a surfactant that enables the polymerization reaction to proceed in water. Without PFOA, the Teflon production process at industrial scale was, at the time, not workable.

The internal documents established the following:

1961: DuPont's own toxicology lab in Delaware exposed rats to PFOA in drinking water. The rats developed enlarged livers — a sign of chemical stress on the organism.

1962: A follow-up study confirmed the liver effects and documented bioaccumulation: PFOA was not excreted but accumulated in the body over time.

Early 1970s: DuPont's own occupational-health program began testing workers' blood. The workers had measurable PFOA levels — hundreds of times higher than what was beginning to appear in the general population.

1981: DuPont's animal-toxicology lab exposed pregnant rats to PFOA. The offspring showed birth defects — primarily cleft palate and microphthalmia (small eyes). DuPont's response was to remove all women from PFOA-handling jobs at the Washington Works plant. The company did not disclose the underlying studies to the EPA.

1984: An internal DuPont memo by senior plant engineer Bill Wynkoop, distributed to senior corporate management, characterized PFOA's environmental persistence and bioaccumulation as "increasingly difficult to defend" and recommended exploring alternatives. The recommendation was not adopted.

1991: A confidential review by DuPont's medical staff concluded that workers at the Washington Works plant had detectable PFOA blood levels approximately 1,000 times higher than members of the general population. The medical staff recommended exposure reductions. They were partially implemented.

1997: DuPont's internal blood-testing program documented PFOA in the blood of every Washington Works worker tested. Some had levels exceeding 1,000 ng/mL — meaning approximately 1 part per million of their blood was PFOA.

1999: At the time Wilbur Tennant called Robert Bilott, DuPont had been releasing PFOA into the Ohio River, into landfills, and into the air around the Washington Works plant for 48 years. The release rate, by DuPont's own internal accounting, was approximately 500,000 pounds (227 metric tonnes) per year at peak operations.

The class action

A small beaker containing PFOA chemical (perfluorooctanoic acid) — a white-yellow waxy solid, photographed on a laboratory bench. — Perfluorooctanoic acid (PFOA, "C8") in a laboratory beaker — the actual chemical at the centre of the DuPont case. PFOA is a white waxy solid at room temperature. It was used as a processing aid in Teflon production from the late 1940s. Wikimedia Commons, CC BY-SA 4.0.

In 2001, Bilott — having spent two years on the Tennant case and having absorbed the implications of the 110,000 internal documents — filed a class-action lawsuit in federal court in Charleston, West Virginia. The lead plaintiff was Joseph Kiger, a high-school teacher from Lubeck, West Virginia. The lawsuit, Leach v. DuPont, sought compensation for approximately 80,000 residents whose drinking water served by six area water utilities had been documented to contain PFOA above 0.05 ppb — the level DuPont's own internal Hazard Communication Group had identified as a working safety threshold in the 1980s.

DuPont contested the lawsuit on grounds that the EPA had not established a regulatory limit for PFOA, that the company's internal threshold was advisory only, and that the connection between specific health outcomes and PFOA exposure had not been established in human studies.

In September 2005, Leach v. DuPont was settled. The terms:

DuPont agreed to install reverse-osmosis filtration on the six affected water systems.
DuPont agreed to fund the C8 Health Project — a comprehensive epidemiological study of approximately 69,000 residents who had consumed PFOA-contaminated water for at least one year between 1950 and 2004.
DuPont agreed to fund the C8 Science Panel — three independent epidemiologists (Tony Fletcher, Kyle Steenland, David Savitz) charged with reviewing the C8 Health Project data and rendering binding "probable link" determinations on specific diseases.
DuPont's settlement payment was approximately $107 million plus the cost of the C8 work.

The settlement preserved each individual plaintiff's right to pursue personal-injury claims separately once a "probable link" determination was rendered.

The C8 Science Panel

The C8 Health Project ran from 2005 to 2006. It collected blood samples and detailed health histories from approximately 69,000 residents. It was, at the time, the largest single environmental- exposure epidemiological study ever conducted. The data set was made publicly available through an arrangement with the West Virginia University School of Medicine.

The C8 Science Panel — Fletcher, Steenland, and Savitz — analyzed the data set against approximately 50 possible health outcomes. They were specifically charged with rendering "probable link" determinations: did the exposure data support a causal connection between PFOA exposure and the specific disease, at the standard of evidence (more probable than not) used in civil litigation?

The Panel issued its final determinations in 2012. Six "probable link" determinations were rendered:

Kidney cancer
Testicular cancer
Thyroid disease
Ulcerative colitis
Pregnancy-induced hypertension (including preeclampsia)
High cholesterol (hypercholesterolemia)

The Panel found no probable link for approximately 30 other health conditions including cardiovascular disease, breast cancer, autoimmune disorders, and most birth defects in offspring of exposed women (the rat-study findings did not consistently replicate in humans at the doses involved).

The "probable link" determinations triggered approximately 3,550 individual personal-injury cases against DuPont under the Leach settlement framework. The cases were consolidated into a multi- district litigation (MDL) in the Southern District of Ohio.

The settlements

The first three MDL bellwether trials, held 2015-2016, resulted in plaintiff verdicts ranging from $1.6 million to $5.6 million per plaintiff. The cases were on appeal when DuPont — and its fluorochemicals spin-off Chemours — settled the entire MDL.

The February 2017 MDL settlement amount was $670.7 million across the approximately 3,550 plaintiffs. The settlement did not constitute an admission of liability. It did include:

DuPont and Chemours's shared responsibility for ongoing C8- related claims, with each party covering 50% of future costs.
The phase-out commitment for PFOA production (already substantially completed by 2015 under the EPA PFOA Stewardship Program).
The continued operation of the reverse-osmosis filtration on affected water systems.

In 2005, separately, the EPA had fined DuPont $16.5 million for the underlying TSCA disclosure failures — the largest U.S. environmental enforcement fine to that date. The 2017 MDL settlement was the second-largest environmental personal-injury settlement in U.S. history.

The frying pan

A Teflon-coated non-stick frying pan, photographed on a kitchen surface — the black PTFE coating visible on the cooking surface, a wooden handle, slight wear on the surface from use. — A Teflon-coated non-stick frying pan. PTFE (polytetrafluoroethylene) — the actual non-stick polymer in Teflon — is itself chemically inert. The toxicity at issue was in PFOA, the processing aid used to manufacture it. Modern Teflon cookware (post-2015 U.S. production) is manufactured without PFOA but with successor fluorochemicals. Wikimedia Commons, CC BY-SA 4.0.

The Teflon frying pan in the home kitchen has, since the 1950s, been a useful object. PTFE is chemically inert; food does not react with it; it does not leach into food at normal cooking temperatures. The pan itself is, in the normal-use sense, safe.

What the DuPont case established was that the manufacture of the pan, not the pan itself, was the problem. PFOA — the processing aid used to make the PTFE — was the toxic substance. It accumulated in the bodies of the workers who manufactured the PTFE, in the environment around the plant, and (through plant emissions and improper disposal) in the water and food chain of the surrounding region.

The contemporary American kitchen — by 2025 — uses Teflon-style cookware manufactured with PFOA-free processes. The successor chemicals (GenX, ADONA, others) have different chemistries but overlap in some properties with PFOA. Whether they are safer at the long-term population scale is, as of 2025, still under investigation.

The "forever chemical" framing — applied broadly to PFAS (per- and poly-fluoroalkyl substances) — characterizes the underlying chemical challenge. The carbon-fluorine bond does not degrade in any biological or environmental process. PFOA, GenX, and approximately 14,000 other PFAS-class chemicals will persist in the environment and in the human body as long as they are produced and not actively removed.

What this case actually is

The DuPont/PFOA case is the modern template for chemical-industry cover-ups in three ways:

The chemistry was useful. PFOA enabled the manufacture of a product (Teflon) that consumers wanted and that had genuine industrial value. The cover-up was not about a worthless product — it was about a chemical that worked extremely well in industrial applications but had non-disclosed toxic effects in human and environmental exposure.
The toxicology was known internally for decades. The 1961 liver-effects study, the 1981 birth-defects study, the 1991 worker-exposure findings — every step of the toxicological case was understood inside DuPont before it was understood outside. The non-disclosure was not a failure to understand; it was a commercial decision.
The legal accountability came from a single attorney. Robert Bilott was not a public-interest lawyer. He was a corporate- defense attorney who took on the case because of a family connection. The 110,000-page document production he forced was the foundation of every subsequent legal and regulatory action. The case is, in this sense, a counter-example to the assumption that corporate environmental misconduct requires a regulatory or public-interest framework to be exposed. A single private attorney in Cincinnati pursued it for twenty years.

The lesson — particularly visible in the parallel cases of benzene, asbestos, lead, and now PFAS more broadly — is that the public's protection against industrial chemicals depends on an information asymmetry being broken. The chemicals are produced; the toxicology is studied internally; the disclosure is not made; the public exposure accumulates. Only after the asymmetry breaks — typically through litigation discovery — does regulation catch up.

PFOA was banned from U.S. production in 2015. By that point, approximately 99% of Americans had it in their blood. The environmental load will continue to bioaccumulate for decades beyond the production end-date. The forever chemicals are forever because the chemistry says so.

The cast

Robert Bilott (b. 1965) — Partner, Taft Stettinius & Hollister (Cincinnati). Took the Tennant case in 1998 and spent the next two decades on PFOA. Author of Exposure (2019). Goldman Environmental Prize 2017.
Wilbur Tennant (1939-2009) — Lubeck, West Virginia cattle farmer. Brought the case to Bilott with the home-video tapes. Died of cancer; his cattle deaths were the precipitating evidence.
Joseph Kiger (b. 1948) — Lubeck high-school teacher; lead plaintiff in Leach v. DuPont class action 2001.
Tony Fletcher — Epidemiologist, London School of Hygiene & Tropical Medicine; C8 Science Panel.
Kyle Steenland — Epidemiologist, Emory University; C8 Science Panel.
David Savitz — Epidemiologist, Brown University; C8 Science Panel.
Bill Wynkoop — DuPont senior plant engineer; 1984 internal memo recommending PFOA replacement.
Joseph R. Goodwin — U.S. District Judge, Southern District of West Virginia; granted the 2000 discovery motion that forced the 110,000-page production.
Charles Holliday (b. 1948) — DuPont CEO 1998-2009; corporate leadership during the disclosure crisis.
Edwin Tennant — Wilbur's brother; co-witness to the early cattle deaths.
Mark Ruffalo (b. 1967) — Plays Bilott in Dark Waters (2019).
Nathaniel Rich — New York Times Magazine journalist; January 2016 long-form article "The Lawyer Who Became DuPont's Worst Nightmare" that catalyzed the popular reception of the case.

What came after

The PFOA case did not end with the 2017 MDL settlement. Several ongoing dimensions:

The successor chemicals. Chemours (the DuPont fluorochemicals spin-off) replaced PFOA with GenX (HFPO-DA) beginning around 2009. The North Carolina state environmental agency identified GenX in the Cape Fear River drinking water in 2017. Litigation parallel to the original PFOA case has been ongoing since 2018.

The broader PFAS class. Approximately 14,000 individual PFAS compounds exist. Regulatory action since 2020 has begun addressing them as a class rather than chemical-by-chemical. The EPA's 2024 PFAS National Primary Drinking Water Regulation set the first federally enforceable limits.

The military bases. Aqueous Film Forming Foam (AFFF), used since the 1960s by U.S. military firefighters for petroleum-fire suppression, contains PFAS compounds. Groundwater contamination around approximately 700 U.S. military installations has been documented. The MDL for AFFF cases was consolidated in South Carolina federal court 2018; a $10.3 billion 3M settlement was announced June 2023.

The international dimension. PFAS contamination has been documented in drinking water in Europe (Vejen, Denmark; Hamburg, Germany), Australia (Williamtown, NSW), and elsewhere. The EU's 2023 restriction of approximately 10,000 PFAS substances is the most aggressive regulatory action to date.

Why this is a "confirmed" case

The DuPont/PFOA cover-up is one of the most extensively documented chemical-industry deception cases in American history. The internal documents are on public record through the 2001 discovery. The toxicology studies are catalogued. The C8 Science Panel's "probable link" determinations have the scientific status of peer-reviewed findings. The 2005 EPA fine and the 2017 MDL settlement are matters of public legal record.

What is sometimes still misunderstood — particularly by general audiences who learned of the case through Dark Waters — is the system the case represents. PFOA was one chemical in one corporation's portfolio. The pattern of internal knowledge, non- disclosure, environmental release, and delayed regulatory action has been the template for an entire class of chemicals across an entire era of American chemical manufacturing.

What we still don't know

The total environmental load. DuPont's own internal records account for partial production volumes; the comprehensive inventory of releases into the Ohio River, into landfills, and into the air around Parkersburg has not been independently audited.

Health effects beyond the six "probable link" diseases. The C8 Science Panel made determinations against a limited set of outcomes. Subsequent epidemiological work has begun to identify additional outcomes (renal disease, dyslipidemia in children, liver damage in adults) that may eventually be added.

Generational effects. PFOA crosses the placenta and is detectable in cord blood. The effects on the second generation — children born to exposed mothers — are still being characterized.

The successor chemicals. GenX and the other PFOA replacements were introduced with the explicit assumption that they were safer. The animal-toxicology evidence has, in some respects, contradicted that assumption. The long-term population studies are not yet available.

Sources

Primary documents:

Leach v. E.I. du Pont de Nemours and Company, Southern District of West Virginia, settled September 2005. Case file and accompanying documents.
In Re: E.I. du Pont de Nemours and Company C-8 Personal Injury Litigation (MDL 2433), Southern District of Ohio, settled February 2017.
EPA Consent Order with DuPont, March 2005 (TSCA disclosure violations; $16.5 million fine).
C8 Health Project Final Report, 2009. West Virginia University School of Medicine.
C8 Science Panel "Probable Link" Determinations, 2011-2012. Multiple reports.
EPA Health Advisory for PFOA, 2009 (revised 2016, 2022).

Secondary investigative reporting: 7. Nathaniel Rich, "The Lawyer Who Became DuPont's Worst Nightmare," New York Times Magazine, January 6, 2016. The single most-cited journalism on the case. 8. Robert Bilott, Exposure: Poisoned Water, Corporate Greed, and One Lawyer's Twenty-Year Battle Against DuPont (Atria, 2019). The participant's first-person account. 9. Mariah Blake, "Welcome to Beautiful Parkersburg, West Virginia: Home to one of the most brazen, deadly corporate gambits in U.S. history," The Huffington Post, 2015. 10. Dark Waters (Todd Haynes, Focus Features, November 2019). Theatrical-release dramatization. 11. The New York Times, multi-correspondent coverage 2015-2024. 12. The Intercept, Sharon Lerner — multi-year PFAS investigation 2015-2023. 13. Bloomberg Businessweek, Paul M. Barrett — DuPont/Chemours investigation.

Academic / scientific scholarship: 14. Steenland, Tony Fletcher, David Savitz, "Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA)" — Environmental Health Perspectives, 2010. 15. Sharon Lerner, "Bad Chemistry: A History of PFAS" — extensive ongoing technical reporting. 16. Erica Schwartz et al., "Per- and Polyfluoroalkyl Substances (PFAS) in Drinking Water: Health Effects and Regulatory Approaches" — Environmental Science & Technology, 2022. 17. Multiple meta-analyses of PFAS health effects, ongoing in Environmental Research and related journals.

Corrections & updates

2026-05-26: First publication.

Inspired this / based on it

FILM

Dark Waters(2019)

Todd Haynes / Focus Features · ★ 7.6

Dramatization with Mark Ruffalo as Bilott, Anne Hathaway, Tim Robbins. Based on the Nathaniel Rich NYT Magazine article.

DOCUMENTARY

The Devil We Know(2018)

Stephanie Soechtig · ★ 7.6

Independent documentary released ahead of Dark Waters; focuses on the Parkersburg community.

BOOK

Exposure: Poisoned Water, Corporate Greed, and One Lawyer's Twenty-Year Battle Against DuPont(2019)

Robert Bilott

The participant's first-person account. Atria Books.

TV SERIES

The Lawyer Who Became DuPont's Worst Nightmare(2016)

Nathaniel Rich / NYT Magazine

The January 2016 long-form article that catalyzed mainstream press attention to the case.

BOOK

Toxic Inheritance: A Modern Tragedy at DuPont(2023)

Sharon Lerner

Investigative journalist's book-length treatment based on a decade of reporting for The Intercept.

DOCUMENTARY

A Drop in the River(2022)

DW Documentary

European documentary on PFAS contamination across multiple countries including ongoing Bilott-era US story.

Filed under

Click any tag for every article carrying it.

Continue reading

CONFIRMED

Big Tobacco's Cancer Cover-Up

On the morning of January 4, 1954, a full-page advertisement appeared in 448 American newspapers under the headline *A Frank Statement to Cigarette Smokers*. It was signed by the chief executives of the United States' six largest tobacco companies. The advertisement assured the American public that 'there is no proof that cigarette smoking is one of the causes of cancer' and that the industry would underwrite scientific research to find the truth. The advertisement had been drafted by John W. Hill of the Hill & Knowlton public-relations firm, hired by the tobacco industry's chief executives at a meeting at the Plaza Hotel in New York on December 14-15, 1953. The strategy that the meeting produced — manufacture doubt about epidemiological evidence the industry already privately accepted, do this through industry-funded research that produced findings inconsistent with the public-health consensus, and continue to sell cigarettes to American smokers while doing so — would be sustained for forty-four years. It would be ended, in 1998, by the Master Settlement Agreement: the largest civil legal settlement in American history at $206 billion across 25 years, paid by the surviving tobacco companies to 46 states, the District of Columbia, and five U.S. territories. By that point, an estimated 8 million Americans had died from smoking-related cancers, cardiovascular disease, and respiratory illness during the cover-up period.

Corporate Cover-ups

1953-1998

An OxyContin 10mg pill photographed in close-up, showing the 'OC' debossed on one side.

CONFIRMED

Purdue Pharma and OxyContin

In December 1995, the U.S. Food and Drug Administration approved a new extended-release oxycodone formulation manufactured by the privately-held Stamford, Connecticut pharmaceutical company Purdue Pharma. The drug was called OxyContin. Its FDA-approved label stated that the controlled-release formulation 'is believed to reduce the abuse liability of the drug.' Within weeks of the January 1996 launch, Purdue's sales force was telling physicians that the risk of addiction was 'less than one percent' — a number drawn from a single 1980 letter to the editor in the *New England Journal of Medicine* that the company would, over the next twenty years, cite approximately 600 times in its promotional materials. The letter had observed 4 cases of addiction in 11,882 hospitalized patients given any opioid for any duration. It was not, by any reasonable standard, evidence for an outpatient sustained-release formulation. By 2010, OxyContin's annual revenue had reached approximately $3.1 billion. By 2017, drug overdose was the leading cause of death for Americans under 50. The cumulative U.S. opioid death toll from 1999 to 2023, by the CDC's count, exceeded 700,000. Purdue Pharma pleaded guilty to federal criminal misbranding charges in 2007 (paying $634.5 million) and again in 2020 (agreeing to $8.3 billion in penalties as part of a bankruptcy reorganization). The Sackler family — owners of Purdue throughout the period — were the subject of a separate $6 billion settlement that was struck down by the U.S. Supreme Court in 2024 (*Harrington v. Purdue Pharma*) and is, as of mid-2026, being renegotiated. Patrick Radden Keefe's 2021 book *Empire of Pain* is the most comprehensive single-volume treatment of the case.

Corporate Cover-ups

1996-2024

Volkswagen's headquarters in Wolfsburg, Germany — the iconic VW high-rise tower.

CONFIRMED

Dieselgate

In late 2013, the International Council on Clean Transportation paid a small team at West Virginia University to put two diesel Volkswagens on the road from Los Angeles to Seattle, hooked up to portable emissions sensors. The team expected to find data confirming what Volkswagen's American marketing campaign had been claiming for years: that 'clean diesel' was real. Instead they found nitrogen-oxide emissions up to forty times the legal limit. Eighteen months later, on September 18, 2015, the U.S. EPA formally accused Volkswagen of installing software in eleven million cars that detected emissions tests and lied to them. By the end of the week, the CEO had resigned and Volkswagen had begun a six-year journey through $34 billion of fines and settlements.

Corporate Cover-ups

2014-2017